| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007841303 |
| P356 | DOI | 10.1038/NM0398-291 |
| P953 | full work available online at | http://www.nature.com/articles/nm0398-291 |
| http://www.nature.com/articles/nm0398-291.pdf | ||
| P698 | PubMed publication ID | 9500601 |
| P5875 | ResearchGate publication ID | 51298339 |
| P50 | author | Dennis Choi | Q5258277 |
| Krzysztof Hyrc | Q72807408 | ||
| Mark P Goldberg | Q96133446 | ||
| P2093 | author name string | J. W. McDonald | |
| D. W. Choi | |||
| S. P. Althomsons | |||
| P2860 | cites work | Molecular Pharmacology | Q1943386 |
| Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
| News on glutamate receptors in glial cells | Q28292403 | ||
| Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue | Q29615225 | ||
| LACUNES: SMALL, DEEP CEREBRAL INFARCTS. | Q33972097 | ||
| Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures | Q34032447 | ||
| Oligodendrocyte origins | Q34418317 | ||
| Cell death and control of cell survival in the oligodendrocyte lineage | Q34460930 | ||
| Glutamate neurotoxicity and diseases of the nervous system | Q34560997 | ||
| Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. | Q36562441 | ||
| In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage | Q36616008 | ||
| Hypoxic-ischemic brain injury in the newborn | Q40916717 | ||
| Effect of kynurenate on functional deficits resulting from traumatic spinal cord injury | Q41099555 | ||
| Pathophysiology of oligodendroglial excitotoxicity | Q41150768 | ||
| Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury | Q41232387 | ||
| AMPA receptors shape Ca2+ responses in cortical oligodendrocyte progenitors and CG-4 cells | Q41300392 | ||
| Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines | Q41440638 | ||
| The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion | Q41563978 | ||
| Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain | Q41883357 | ||
| Cerebral white matter is highly vulnerable to ischemia | Q42522490 | ||
| Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose | Q43840051 | ||
| Non-NMDA receptor-mediated neurotoxicity in cortical culture | Q45283851 | ||
| CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. | Q46020332 | ||
| Conformationally defined neurotransmitter analogs. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer | Q46602656 | ||
| Oxidative stress induces apoptosis in embryonic cortical neurons. | Q48226359 | ||
| Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury | Q48244677 | ||
| Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate | Q48245939 | ||
| AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h | Q48268778 | ||
| Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention | Q48316824 | ||
| Diazoxide blocks glutamate desensitization and prolongs excitatory postsynaptic currents in rat hippocampal neurons | Q48403898 | ||
| Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system | Q48411524 | ||
| Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture | Q48595292 | ||
| Glycoprotein Processing Is Required for Completion But Not Initiation of Oligodendroglial Differentiation from Its Bipotential Progenitor Cell | Q48605890 | ||
| Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis | Q48609930 | ||
| Susceptibility to apoptosis is enhanced in immature cortical neurons | Q48683896 | ||
| Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures | Q48871596 | ||
| Experimental cyanide encephalopathy: electron microscopic observations of early lesions in white matter | Q51216308 | ||
| Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy | Q51292054 | ||
| Delayed neurological deterioration after anoxia | Q51293981 | ||
| Local and distant neuronal degeneration following intrastriatal injection of kainic acid | Q51876607 | ||
| Development of binding sites for excitatory amino acids in cultured cerebral cortex neurons | Q52238607 | ||
| AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked | Q54154185 | ||
| Glutamate neurotoxicity in cortical cell culture | Q54412952 | ||
| Demyelination and remyelination after acute spinal cord compression | Q54495189 | ||
| Conduction in myelinated, unmyelinated, and demyelinated fibers | Q56609207 | ||
| Development of excitatory amino acid induced cytotoxicity in cultured neurons | Q68086189 | ||
| Physiological and pathophysiological roles of excitatory amino acids during central nervous system development | Q68466342 | ||
| The pathogenesis of carbon monoxide encephalopathy in the acute phase?Physiological and morphological correlation | Q70780795 | ||
| Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro | Q70940537 | ||
| Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix | Q71612409 | ||
| Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX | Q72816547 | ||
| In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, rip | Q93524085 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | excitotoxicity | Q901117 |
| oligodendrocyte | Q916698 | ||
| P304 | page(s) | 291-297 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Nature medicine | Q1633234 |
| P1476 | title | Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity | |
| P478 | volume | 4 |
| Q37405017 | 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain |
| Q48319077 | 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion |
| Q28593662 | 3-Phosphoglycerate dehydrogenase, a key enzyme for l-serine biosynthesis, is preferentially expressed in the radial glia/astrocyte lineage and olfactory ensheathing glia in the mouse brain |
| Q43558063 | 4-Hydroxynonenal, a lipid peroxidation byproduct of spinal cord injury, is cytotoxic for oligodendrocyte progenitors and inhibits their responsiveness to PDGF. |
| Q44813452 | 5-fluorouracil-induced oligodendrocyte death and inhibitory effect of cycloheximide, Trolox, and Z-VAD-FMK in murine cortical culture. |
| Q49070894 | A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia |
| Q50516298 | A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death |
| Q46040083 | A novel animal model for neuroinflammation and white matter degeneration. |
| Q48533469 | A patient with delayed posthypoxic demyelination: a case report of hyperbaric oxygen treatment |
| Q47875735 | A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices |
| Q44068712 | AMPA receptor-mediated toxicity in oligodendrocyte progenitors involves free radical generation and activation of JNK, calpain and caspase 3. |
| Q43823406 | AMPA-Induced suppression of oligodendroglial gene expression in neonatal rat brain. |
| Q37774406 | AMPA-receptor trafficking and injury-induced cell death. |
| Q37409619 | Abnormalities in white matter microstructure associated with chronic ketamine use. |
| Q57975136 | Activation of Kainate Receptors Sensitizes Oligodendrocytes to Complement Attack |
| Q26851322 | Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia |
| Q55475068 | Akt-mediated survival of oligodendrocytes induced by neuregulins. |
| Q35929543 | Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes |
| Q48416073 | Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit composition and cAMP-response element-binding protein regulate oligodendrocyte excitotoxicity |
| Q44680668 | Altered hippocampal myelinated fiber integrity in a lithium-pilocarpine model of temporal lobe epilepsy: A histopathological and stereological investigation |
| Q43638894 | Ampa/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. |
| Q44622932 | An Electrophysiological Model of Spinal Transmission Deficits in Mouse Experimental Autoimmune Encephalomyelitis |
| Q92105044 | An MRI Study of the Metabolic and Structural Abnormalities in Obsessive-Compulsive Disorder |
| Q34452140 | Anoxic and Ischemic Injury of Myelinated Axons in CNS White Matter: From Mechanistic Concepts to Therapeutics |
| Q37172810 | Anti-seizure activity of flower extracts of Nepeta bractaeta in Swiss albino mice |
| Q48924173 | Approaches to neuroprotective and reperfusion injury therapy |
| Q38055562 | Approaches to repairing the damaged spinal cord: overview |
| Q36946523 | Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. |
| Q34677050 | Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors |
| Q36878427 | Astrocytes--friends or foes in multiple sclerosis? |
| Q91725302 | Astrocytic connexin 43 potentiates myelin injury in ischemic white matter disease |
| Q73308222 | Autoimmune encephalomyelitis ameliorated by AMPA antagonists |
| Q36657652 | Autoimmune modulation of astrocyte-mediated homeostasis. |
| Q34686890 | Autophagy, inflammation and neurodegenerative disease |
| Q38653397 | Axonal degeneration in multiple sclerosis: defining therapeutic targets by identifying the causes of pathology |
| Q42913988 | Axons get excited to death |
| Q35531951 | Axon–glia synapses are highly vulnerable to white matter injury in the developing brain |
| Q30493846 | BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. |
| Q50542236 | Bax and calpain mediate excitotoxic oligodendrocyte death induced by activation of both AMPA and kainate receptors. |
| Q42464099 | Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. |
| Q37253850 | Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances |
| Q58885887 | COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of ?765G>C with disease risk |
| Q35144325 | Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors |
| Q44628433 | Caspase-Dependent and Caspase-Independent Oligodendrocyte Death Mediated by AMPA and Kainate Receptors |
| Q37267652 | Caspases determine the vulnerability of oligodendrocytes in the ischemic brain |
| Q35002711 | Cell death in models of spinal cord injury |
| Q45045272 | Cerebral white matter injury and damage to myelin sheath following whole-brain ischemia |
| Q42099730 | Characterization of acid-sensing ion channel expression in oligodendrocyte-lineage cells |
| Q44675641 | Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes |
| Q34506808 | Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression |
| Q28576662 | Chronic cocaine administration causes extensive white matter damage in brain: diffusion tensor imaging and immunohistochemistry studies |
| Q36707167 | Classical 18.5-and 21.5-kDa isoforms of myelin basic protein inhibit calcium influx into oligodendroglial cells, in contrast to golli isoforms |
| Q41790710 | Cocaine-Induced Loss of White Matter Proteins in the Adult Mouse Nucleus Accumbens Is Attenuated by Administration of a β-Lactam Antibiotic during Cocaine Withdrawal |
| Q53602011 | Complex interplay between glutamate receptors and intracellular Ca2+ stores during ischaemia in rat spinal cord white matter |
| Q80817756 | Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia |
| Q46146800 | Conduction block and glial injury induced in developing central white matter by glycine, GABA, noradrenalin, or nicotine, studied in isolated neonatal rat optic nerve. |
| Q90258569 | Continuous cuprizone intoxication allows active experimental autoimmune encephalomyelitis induction in C57BL/6 mice |
| Q30619667 | Crmp4 deletion promotes recovery from spinal cord injury by neuroprotection and limited scar formation |
| Q40904210 | Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line |
| Q44972170 | Cytosolic zinc accumulation contributes to excitotoxic oligodendroglial death |
| Q36090107 | Demyelination as a rational therapeutic target for ischemic or traumatic brain injury |
| Q38186202 | Demyelination in multiple sclerosis |
| Q48149315 | Different nitric oxide synthase inhibitors cause rapid and differential alterations in the ligand-binding capacity of transmitter receptors in the rat cerebral cortex |
| Q37091141 | Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures |
| Q48117243 | Differential expression of brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 in the adult rat spinal cord: regulation by the glutamate receptor agonist kainic acid. |
| Q46736957 | Differential oxidative stress in oligodendrocytes and neurons after excitotoxic insults and protection by natural polyphenols. |
| Q30592331 | Diffusion Tensor Imaging Findings of White Matter Changes in First Episode Schizophrenia: A Systematic Review |
| Q36114803 | Disorders of intermediary metabolism: toxic leukoencephalopathies |
| Q33709233 | Drug development for stroke: importance of protecting cerebral white matter |
| Q28566860 | Dual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte death |
| Q38170257 | Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration |
| Q43246648 | Dysmyelinated axons in shiverer mice are highly vulnerable to alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor-mediated toxicity |
| Q49137983 | Early onset of demyelination after N-methyl-D-aspartate lesions of the lateral hypothalamus |
| Q44410733 | Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model |
| Q48188118 | Effects of kainate-mediated excitotoxicity on the expression of rat counterparts of A170 and MSP23 stress proteins in the brain |
| Q43680252 | Endogenous opioids and oligodendroglial function: possible autocrine/paracrine effects on cell survival and development |
| Q28506238 | Enhanced Oligodendrocyte Survival after Spinal Cord Injury in Bax-Deficient Mice and Mice with Delayed Wallerian Degeneration |
| Q28202177 | Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders |
| Q36822954 | Excitotoxic damage to white matter. |
| Q48273500 | Excitotoxic mechanisms of ischemic injury in myelinated white matter |
| Q46488778 | Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition |
| Q34768751 | Excitotoxicity in glial cells. |
| Q57975140 | Expression of glutamate transporters in rat optic nerve oligodendrocytes |
| Q48227856 | Expression of glutamate transporters in the adult bovine corpus callosum |
| Q48453039 | Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury |
| Q47710346 | Extracellular Acidity Potentiates AMPA Receptor-Mediated Cortical Neuronal Death |
| Q48910324 | Functional ionotropic glutamate receptors on peripheral axons and myelin |
| Q37312220 | General control nonderepressible 2 (GCN2) kinase protects oligodendrocytes and white matter during branched-chain amino acid deficiency in mice |
| Q35201289 | Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis |
| Q64963645 | Glial Cell AMPA Receptors in Nervous System Health, Injury and Disease. |
| Q46097376 | GluR2-free alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis |
| Q34125992 | Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner. |
| Q38750023 | Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology |
| Q60450917 | Glutamate excitotoxicity in a model of multiple sclerosis |
| Q28475977 | Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction |
| Q46959335 | Glutamate receptor expression in multiple sclerosis lesions |
| Q28290774 | Glutamate receptor ion channels: structure, regulation, and function |
| Q33953259 | Glutamate receptors in glia: new cells, new inputs and new functions |
| Q21284455 | Glutamate receptors in neuroinflammatory demyelinating disease |
| Q33410173 | Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors |
| Q41612066 | Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors |
| Q35632609 | Glutamate receptors: the cause or cure in perinatal white matter injury? |
| Q43726770 | Glutamate release promotes growth of malignant gliomas |
| Q48154073 | Glutamate transporter EAAC1 is expressed in neurons and glial cells in the rat nervous system |
| Q34027783 | Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in human periventricular leukomalacia. |
| Q28190140 | Glutamate uptake |
| Q36277315 | Glutamate-mediated glial injury: mechanisms and clinical importance |
| Q48606111 | Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation. |
| Q92871147 | Glutamatergic signaling between neurons and oligodendrocyte lineage cells: Is it synaptic or non-synaptic? |
| Q40445521 | Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: a novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency |
| Q48161625 | Glutaric aciduria type I: pathomechanisms of neurodegeneration. |
| Q48256619 | Glycine antagonist and NO synthase inhibitor protect the developing mouse brain against neonatal excitotoxic lesions |
| Q44129729 | Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. |
| Q43774251 | Group I metabotropic glutamate receptors limit AMPA receptor-mediated oligodendrocyte progenitor cell death |
| Q41712134 | HCMV induces dysregulation of glutamate uptake and transporter expression in human fetal astrocytes |
| Q34343628 | HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases |
| Q82915770 | How to repair an ischemic brain injury? Value of experimental models in search of answers |
| Q24525274 | Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha |
| Q42745798 | Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors |
| Q77388012 | Hypoxic-Ischemic Oligodendroglial Injury in Neonatal Rat Brain |
| Q44813370 | IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors |
| Q28771339 | Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemia |
| Q35052754 | Increased expression of cystine/glutamate antiporter in multiple sclerosis |
| Q40051762 | Increased expression of golli myelin basic proteins enhances calcium influx into oligodendroglial cells |
| Q36896275 | Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury |
| Q57110813 | Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade |
| Q35049393 | Inhibition of NADPH oxidase activation in oligodendrocytes reduces cytotoxicity following trauma |
| Q35815842 | Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination |
| Q34762681 | Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2). |
| Q38345502 | Integrative genome-wide association analysis of cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders |
| Q42132214 | Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes |
| Q44630169 | Intracerebral injection of AMPA causes axonal damage in vivo |
| Q38635972 | Intraspinal TLR4 activation promotes iron storage but does not protect neurons or oligodendrocytes from progressive iron-mediated damage. |
| Q46514027 | Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis |
| Q44722626 | Involvement of nitric oxide on kainate-induced toxicity in oligodendrocyte precursors. |
| Q73666122 | Ion channels in glial cells |
| Q27691821 | Ionic regulation of cell volume changes and cell death after ischemic stroke |
| Q73570854 | Iron supplementation aggravates periventricular cystic white matter lesions in newborn mice |
| Q91710126 | Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells |
| Q46078205 | Ischemic injury to white matter: an age-dependent process |
| Q55475145 | KA1-like kainate receptor subunit immunoreactivity in neurons and glia using a novel anti-peptide antibody. |
| Q43054155 | Kainate-mediated excitotoxicity induces neuronal death in the rat spinal cord in vitro via a PARP-1 dependent cell death pathway (Parthanatos). |
| Q46369698 | Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury |
| Q52151873 | Lipopolysaccharide-Induced Apoptosis of Astrocytes: Therapeutic Intervention by Minocycline |
| Q36366723 | Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes |
| Q47820010 | Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia |
| Q63915705 | Lysophosphatidic acid receptor type 2 activation contributes to secondary damage after spinal cord injury in mice |
| Q24648789 | Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes |
| Q73387347 | Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter |
| Q35120144 | Mechanisms, challenges and opportunities in stroke |
| Q38008505 | Metabolic injury to axons and myelin |
| Q37358875 | Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia. |
| Q42958588 | Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. |
| Q43589250 | Microglia/macrophages proliferate in striatum and neocortex but not in hippocampus after brief global ischemia that produces ischemic tolerance in gerbil brain |
| Q36215217 | Minocycline as a neuroprotective agent |
| Q38040792 | Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis |
| Q35580651 | Molecular biology of cervical myelopathy and spinal cord injury: role of oligodendrocyte apoptosis |
| Q35634506 | Myelin inhibitors: does NO mean GO? |
| Q45394547 | Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. |
| Q73315790 | NBQX attenuates excitotoxic injury in developing white matter |
| Q38157889 | NMDA Receptors in Glial Cells: Pending Questions |
| Q46863661 | NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury |
| Q46863665 | NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia |
| Q43807517 | Na+–K+-ATPase inhibition and depolarization induce glutamate release via reverse Na+-dependent transport in spinal cord white matter |
| Q34407686 | Neurobiology of Periventricular Leukomalacia in the Premature Infant |
| Q37755972 | Neurobiology of injury to the developing brain |
| Q97570182 | Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms |
| Q34727045 | Neuronal NAMPT is released after cerebral ischemia and protects against white matter injury |
| Q92578008 | Neurotoxic potential of reactive astrocytes in canine distemper demyelinating leukoencephalitis |
| Q24671657 | Neurotransmitter receptors in the life and death of oligodendrocytes |
| Q36113042 | Nitric oxide and multiple sclerosis |
| Q33180241 | Non-N-methyl-D-aspartate glutamate receptors mediate oxygen--glucose deprivation-induced oligodendroglial injury |
| Q48867900 | Novel hypoglycemic injury mechanism: N-methyl-D-aspartate receptor-mediated white matter damage |
| Q35625437 | Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review. |
| Q36074474 | Novel toxicity of the unedited GluR2 AMPA receptor subunit dependent on surface trafficking and increased Ca2+-permeability. |
| Q28205804 | Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors |
| Q38076363 | Oligodendrocyte N-Methyl-d-aspartate Receptor Signaling: Insights into Its Functions |
| Q35208769 | Oligodendrocyte birth and death following traumatic brain injury in adult mice |
| Q42244794 | Oligodendrocyte degeneration and recovery after focal cerebral ischemia. |
| Q48588078 | Oligodendrocyte excitotoxicity determined by local glutamate accumulation and mitochondrial function |
| Q38202292 | Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia |
| Q30051584 | Oligodendrocytes: biology and pathology |
| Q35073606 | Oligodendroglia in developmental neurotoxicity |
| Q48938399 | Oligodendroglial cell death with DNA fragmentation in the white matter under chronic cerebral hypoperfusion: comparison between normotensive and spontaneously hypertensive rats |
| Q37008474 | Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury |
| Q37243989 | P2X7 receptors in oligodendrocytes: a novel target for neuroprotection |
| Q28235168 | Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways |
| Q27000069 | Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models |
| Q30790294 | Pathophysiology of glia in perinatal white matter injury |
| Q32164691 | Perinatal brain injury: from pathogenesis to neuroprotection |
| Q33863397 | Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders |
| Q43764930 | Phosphorylation of cyclic adenosine monophosphate response element binding protein in oligodendrocytes in the corpus callosum after focal cerebral ischemia in the rat. |
| Q48330654 | Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter |
| Q42407107 | Potential Benefit of the Charge-Stabilized Nanostructure Saline RNS60 for Myelin Maintenance and Repair. |
| Q35699016 | Potentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase |
| Q48409149 | Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. |
| Q28574864 | ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury |
| Q73583745 | Quantitative immunochemistry on neuronal loss, reactive gliosis and BBB damage in cortex/striatum and hippocampus/amygdala after systemic kainic acid administration |
| Q73338076 | Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop |
| Q28248202 | Reactive astrocytes protect tissue and preserve function after spinal cord injury |
| Q41136819 | Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System |
| Q34361149 | Recent advances in human perinatal white matter injury |
| Q92622351 | Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation |
| Q35046922 | Remyelinating strategies for the treatment of multiple sclerosis |
| Q37908512 | Reprint of “The developing oligodendrocyte: key cellular target in brain injury in the premature infant” |
| Q35209243 | RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury |
| Q44616100 | Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis |
| Q64118530 | Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders |
| Q36943381 | Role of cytokine p40 family in multiple sclerosis |
| Q34337582 | Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress |
| Q37988411 | Roles of Activated Microglia in Hypoxia Induced Neuroinflammation in the Developing Brain and the Retina |
| Q30682992 | Salvaging the ischaemic penumbra: more than just reperfusion? |
| Q42107950 | Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects |
| Q46054884 | Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia. |
| Q34310129 | Self-induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity |
| Q33844576 | Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists |
| Q48772612 | Sodium transport through the cerebral sodium-glucose transporter exacerbates neuron damage during cerebral ischaemia |
| Q48137954 | Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation |
| Q34530651 | Spinal-cord injury |
| Q89977191 | Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium |
| Q46830854 | Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects |
| Q37219369 | Synapses on NG2-expressing progenitors in the brain: multiple functions? |
| Q35897355 | Synaptic and extrasynaptic neurotransmitter receptors in glial precursors' quest for identity. |
| Q26768210 | Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage |
| Q38040207 | Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury. |
| Q36415334 | TNFalpha-induced AMPA-receptor trafficking in CNS neurons; relevance to excitotoxicity? |
| Q46806998 | Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. |
| Q92765544 | Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network |
| Q44538522 | Temporal and spatial distribution of activated caspase-3 after subdural kainic acid infusions in rat spinal cord |
| Q42487488 | Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain |
| Q38111457 | The Therapeutic Role of Interleukin-10 after Spinal Cord Injury |
| Q33678157 | The changing landscape of ischaemic brain injury mechanisms. |
| Q34995998 | The developing oligodendrocyte: key cellular target in brain injury in the premature infant |
| Q90288376 | The effect of age-related risk factors and comorbidities on white matter injury and repair after ischemic stroke |
| Q33516828 | The encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined |
| Q33546981 | The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype |
| Q34800004 | The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death |
| Q48268110 | The glutamate transporter EAAT2 is transiently expressed in developing human cerebral white matter |
| Q28370052 | The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease |
| Q37144604 | The injured nervous system: a Darwinian perspective. |
| Q48925925 | The ischemic cascade and mediators of ischemic injury |
| Q40843715 | The lethal expression of the GluR2flip/GluR4flip AMPA receptor in HEK293 cells |
| Q48543327 | The neuropathological and behavioral consequences of intraspinal microglial/macrophage activation |
| Q34783988 | The role of glutamate receptor maturation in perinatal seizures and brain injury |
| Q77846814 | The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS |
| Q43613142 | Transient expression of the NG2 proteoglycan by a subpopulation of activated macrophages in an excitotoxic hippocampal lesion |
| Q42089327 | Transplantation of Mesenchymal Stem Cells Promotes an Alternative Pathway of Macrophage Activation and Functional Recovery after Spinal Cord Injury |
| Q33183064 | Two Temporal Stages of Oligodendroglial Response to Excitotoxic Lesion in the Gray Matter of the Adult Rat Brain |
| Q40693774 | Type-2 astrocyte-like cells are more resistant than oligodendrocyte-like cells against non-N-methyl-D-aspartate glutamate receptor-mediated excitotoxicity |
| Q37896626 | Understanding aberrant white matter development in schizophrenia: an avenue for therapy? |
| Q37956307 | Understanding the roles of the kynurenine pathway in multiple sclerosis progression. |
| Q36275086 | Vesicular release of glutamate from unmyelinated axons in white matter |
| Q41453076 | Vulnerability of premyelinating oligodendrocytes to white-matter damage in neonatal brain injury |
| Q47577445 | White matter axon vulnerability to AMPA/kainate receptor-mediated ischemic injury is developmentally regulated. |
| Q31080285 | White matter injury in ischemic stroke |
| Q38231843 | White matter injury: Ischemic and nonischemic. |
| Q73302944 | White matter ischaemia |
| Q46767725 | White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. |
| Q37983518 | Zinc homeostasis and signaling in glia |
Search more.